Personalized warfarin therapy developed

Feb. 26, 2010 at 3:13 PM

COLUMBUS, Ohio, Feb. 26 (UPI) -- U.S. researchers say their new rapid, genotyping method can help clinicians choose appropriate doses of the blood thinner warfarin for individual patients.

Researchers at Ohio State University in Columbus, led by Dr. Haifeng Wu, say their rapid, genotyping method can identify the single nucleotide polymorphisms that affect use of warfarin -- a drug commonly prescribed to prevent blood clots.

Warfarin, also known as Coumadin, needs to be closely monitored because dosing is complicated by interactions with some foods and other drugs, Wu says.

"On-site application of this method in hospital laboratories will greatly help clinicians to determine appropriate doses of warfarin to treat patients with thromboembolic disorders," study authors said in a statement.

The study was published in the Journal of Molecular Diagnostics.

Related UPI Stories
Latest Headlines
Trending Stories
House Majority Leader Kevin McCarthy drops bid for speaker
WikiLeaks offering $50K for video of Afghan hospital bombing
Murdoch sorry for implying Obama's not a 'real black president'
Reid sues exercise companies over eye injury
Lumber Liquidators to pay $10M in DOJ settlement